Mechanisms of Disease 1 HC6: Mechanisms of adaptive immunity
HC6: Mechanisms of adaptive immunity
T-cell activation
There are several types of lymphocytes:
- CD8 T-cell
- Mass destructors → kill cells
- B-cell
- Production of antibodies
- Regulatory T-cell
- Dampen everything
- CD4 T-cell
- Mostly helper-cells → aid other cells in fighting pathogens
There are 2 types of MHC molecules, which are distinguished by their peptides being produced in 2 different cellular compartments:
- MHC class I: peptides derived from protein synthesis by the presenting cell → the antigen is produced by the cell itself
- An exception is cross-presentation of endocytosed proteins on MHC class I molecules
- Can be expressed by all nucleated cells
- CD8 T-cells bind to the a3domain of MHC class I
- The cell is infected and needs to be cleared
- MHC class II: peptides derived from endocytosed proteins → the antigen is taken up from the surroundings
- These proteins are extracellular
- Can be expressed by all antigen-presenting cells
- Dendritic cells always present MHC class II
- CD4 T-cells bind to the b2domain of MHC class II
- The cell itself isn't infected and doesn't need to be cleared
How do T-cells get activated?
Activation of the adaptive immune system starts when T-cells are activated. T-cells get activated by antigen presenting cells. Antigen presenting cells are part of the innate immune system:
- Dendritic cells, macrophages or neutrophils engulf pathogens such as bacteria and viruses and digest these to obtain antigens
- The bacteria is engulfed by a phagosome, which fuses with a lysosome that degrades the bacteria into smaller particles
- Lysosomes have enzymes and a very low pH
- The bacteria is engulfed by a phagosome, which fuses with a lysosome that degrades the bacteria into smaller particles
- The cells present the foreign antigens with MHC molecules on their surface
- A naive T-cell binds transiently to the antigen presenting cell it meets
- The TCR screens the peptide through the MHC-complex
- The TCR delivers an antigen-specific signal
- T-cell-antigen presenting cell interaction is stabilized for days
- A second signal is required to trigger activation of the naive T-cell → co-stimulation
- Co-stimulation plays an important role → the combination of an antigen-specific signal and a co-stimulatory signal is required to activate a naive T-cell
- The co-signal is derived from an alarm signal from the dendritic cell
- A B7 unit is expressed → IL-2 production
- If there isn't any B7 expression, the T-cell won't be activated
- A B7 unit has a CD80 or CD86 receptor, which will connect to CD28 on the naive T-cell
- A B7 unit is expressed → IL-2 production
- Activated T-cells switch on the expression of various genes, including interleukin-2 (IL-2)
- IL-2 drives proliferation and differentiation of activated naive T-cells
- Naive T-cells express the low affinity IL-2 receptor, activated cells express the high-affinity receptor
- Immunosuppressive drugs act by suppressing IL-2 production or action → T-cell responses are dampened
- For example cyclosporin, tacrolimus and rapamycin
- IL-2 drives proliferation and differentiation of activated naive T-cells
In conclusion:
- T-cells can only be activated when the antigen is presented → an antigen alone drifting near a T-cell doesn't evoke a response
- Signal 1 is the connection between the MHC molecule and the T-cell receptor
- This strongly locked by the CD4 connection
- Signal 2 is the danger signal from the dendritic cell → the B7 unit connecting to the C28
If there isn't any danger signal, the T-cell normally lets go. If it doesn't let go, there's something wrong with the T-cell because it responds to things that aren't important → the T-cell becomes anergic. It's an inactivated but alive T-cell that is unresponsive.
The presence of co-stimulatory molecules (like B7) is upregulated by microbial or pathogenic substances. They increase the expression of co-stimulatory molecules on the antigen presenting cell (APC) → they play an import role in creating danger signal in T- and B-cell activation.
Where does activation take place?
There are multiple sites involved in activation of adaptive immunity:
- Dendritic cells pick up the antigen
- The dendritic cells transport it to the draining lymph node
- In the lymph node, they stimulate adaptive immunity by presenting the antigen on their MHC molecules
- Once the right T-cell has found its antigen, the adaptive immune response kicks in
There are several pathways used by dendritic cells to process and present antigens:
- Receptor mediated endocytosis of bacteria
- MHC class II
- CD4 T-cell
- Macropinocytosis of bacteria or viruses
- MHC class II
- CD4 T-cell
- Viral infection
- MHC class I
- CD8 T-cell
- Cross-presentation of exogenous viral antigens
- MHC class I
- CD8 T-cell
- Transfer of viral antigens from infected dendritic cell to resident dendritic cell
- MHC class I
- CD8 T-cell
When a T-cell has entered the lymph node, the following happens:
- T-cells enter a lymph node across high endothelial venules in the cortex
- T-cells monitor antigens presented by macrophages and dendritic cells
- Endothelial cells start expressing receptors which T-cells can use to enter the lymph node
- T-cells that do not encounter a specific antigen leave the node in the efferent lymph
- T-cells that encounter a specific antigen proliferate and differentiate to effector cells
This whole process takes about 4 days for naive T-cells → adaptive immunity takes some time to kick in. Memory cells can get activated quicker.
What happens when T-cells get activated?
After a T-cell is activated, the following happens:
- Proliferation
- Cell division and clonal expansion
- Differentiation: depending on the pathogen, the necessary function is different → different kinds of T-cells are made
- Secretion of cytokines
- Death
- Important for down-regulation of immune response
Mature dendritic cells can activate CD4 T-cells:
- A mature dendritic cell presents its antigen via the MHC class II molecule to a naive CD4 T-cell
- The naive CD4 T-cell is activated and proliferates
- This is all dependent of the IL-2 cytokine
- Depending on the cytokines present in the micro-environment, the T-cell differentiates to a type of T-cell
- Th1-cell: a T-helper cell important for fighting intracellular pathogens
- Th2-cell: a T-helper cell for B-cell responses against extracellular pathogens
- Promotes production of antibodies by B-cells
- Th17-cell: a T-helper cell for combatting infections of skin and mucosa and autoinflammation
- For example fungi
- iTreg-cell: a regulatory T-cell that dampens everything
Mature dendritic cells can also activate CD8 T-cells, cytolytic or cytotoxic T-cells. These connect to MHC class I molecules. CD8 T-cells require a stronger co-stimulatory activity than needed to activate CD4 T-cells. In case of a weak co-stimulatory activity, CD4 T-cells can help:
- CD4-derived cytokines can increase co-stimulation by for example increasing B7 on APC
- CD4-derived cytokines such as IL-2 can activate CD8-cells directly
Cytotoxic T-cells can kill several infected cells in succession:
- A cytotoxic CD8 T-cell recognizes a virus-infected cell
- The CD8 T-cell programs the first target cell to die
- The CD8 T-cell moves on to the second target cell
- The first target cell dies, the second is dying and the third is being attacked
In conclusion, activation of memory T-cells by an antigen presenting cell is less demanding than activation of naive T-cells.
B-cell activation
How do B-cells get activated?
In the first place, B-cells are activated by the crosslinking of a B-cell receptor with antigens → an antigen-specific signal. However, additional signals are required for B-cell activation → the B-cell co-receptor complex:
- CD21/CR2: actually binds to the bacteria
- CD19: a signaling chain that, once CR2 is connected, signals to the B-cell
- CD18: unknown function but is very necessary
The B-cell receptor and B-cell co-receptor cooperate in B-cell activation. For most antigens, even more signals are required → they are T-cell dependent. There are 2 types of antigens:
- T-cell independent antigens → quick, but not very high affinity
- Do not require help of T-cells for activation of B-cells
- No induction of B-cell memory
- No class switching → only produces IgM
- For example bacterial polysaccharides with repeating epitopes
- Problematic for vaccine development
- T-cell dependent antigens
- Require CD4 cells
- Induction of B-cell memory
- Class switching is possible
In case of T-cell-independent B-cell activation, B-cells become activated when their receptors are cross-linked by antigens → antibody production. This response isn't of a very high quality.
In case of T-cell-dependent B-cell activation, specialized Th2 cells stimulate the proliferation and differentiation of naive B-cells:
- A B-cell binds to an antigen and presents it on their MHC class II to the T-cells
- The TFH-cell recognizes a peptide derived from the B-cells antigen
- A TFH-cell is a follicular helper cell
- This is basically a Th2-cell
- A TFH-cell is a follicular helper cell
- The naive B-cell and TFH-cell exchange signals that begin the process of B-cell activation
- For example IL-2
- The B-cell starts to activate → becomes a plasma cell
The T-cell can also encounter the same antigen presented by a dendritic cell, which also will lead to it presenting IL-2 → this will eventually also activate the B-cell. In conclusion, B-cells can be activated by T-cells responding to B-cells or by T-cells responding to dendritic cells.
How is unwanted activation regulated?
During activation, multiple measures are taken to prevent unwanted responses:
- Selection during maturation in the bone marrow or thymus
- Binding to self-antigens can lead to deletion or inactivation of immature B-cells in the bone marrow
- T-cells that show affinity for MHC-molecules presented by cortex thymic epithelial cells are positively selected in the thymus
- T-cells specific for and binding too strongly to self-antigens are removed in the thymus by negative selection
- Regulation of B- and T-cell responses after the cells have left the primary lymphoid organs
- Anergy
- Regulatory T-cells that dampen the immune response
What is the function of antibodies?
Antibodies have many different effector functions:
- Neutralization of toxins → ensure that they're not recognized anymore by the immune system
- Inhibition of adherence to the epithelium
- Complementing activation
- Fc receptors and complement receptors provide opsonization
There are many immunoglobulin isotypes:
- IgG
- IgE
- IgD
- IgM
- IgA
Clinical examples
Asthma:
If a Th2 response goes wrong, it can cause an immune response against an allergen that isn't dangerous. This happens in case of asthma:
- Peptides of a degraded allergen are presented by an antigen-presenting cell
- A naive T-cell starts to promote a Th2 response
- The Th2 response promotes the development of B-cells that promote the recruitment of innate immune cells
- A cascade of inflammatory responses is activated
Immunotherapy:
In case of adoptive T-cell transfer, the adaptive immune system is used as a base for cancer immunotherapy:
- Cytotoxic T-cells are taken out of the patient's body
- They're in-vitro selected for their tumor-antigen
- They're expanded in-vitro
- They're put back into the body
This creates a high amount of CD8 T-cells that have a high affinity for the tumor and starts to destroy it.
The danger signal is important to activate T-cells, but it also initiates the expression of PD-L1 on the antigen-presenting cell → it connects PD1 to PD-L1. This complex has a higher affinity for CD28 than the B7-receptor → it inhibits the activation through negative feedback. It prevents over-responsion. Tumors can take advantage of this system by starting to express PD-L1 in order to deactivate T-cells instead of killing them. By inhibiting this system, the T-cell can be reactivated again to target the tumor.
Join with a free account for more service, or become a member for full access to exclusives and extra support of WorldSupporter >>
Concept of JoHo WorldSupporter
JoHo WorldSupporter mission and vision:
- JoHo wants to enable people and organizations to develop and work better together, and thereby contribute to a tolerant and sustainable world. Through physical and online platforms, it supports personal development and promote international cooperation is encouraged.
JoHo concept:
- As a JoHo donor, member or insured, you provide support to the JoHo objectives. JoHo then supports you with tools, coaching and benefits in the areas of personal development and international activities.
- JoHo's core services include: study support, competence development, coaching and insurance mediation when departure abroad.
Join JoHo WorldSupporter!
for a modest and sustainable investment in yourself, and a valued contribution to what JoHo stands for
- Login of registreer om te kunnen reageren
- 1584 keer gelezen
Mechanisms of Disease 1 2020/2021 UL
- Mechanisms of Disease 1 HC1: Introduction to G2MD1
- Mechanisms of Disease 1 HC2: Introduction to the immune system
- Mechanisms of Disease 1 HC3: Innate and adaptive immune responses & key cytokines
- Mechanisms of Disease 1 HC4: Pathology of normal immune response
- Mechanisms of Disease 1 HC5: B- and T-cell generation and diversity
- Mechanisms of Disease 1 HC6: Mechanisms of adaptive immunity
- Mechanisms of Disease 1 HC7: Effector mechanisms of antibodies
- Mechanisms of Disease 1 HC8: B-cell development and antibodies
- Mechanisms of Disease 1 HC9: Tissue injury and repair
- Mechanisms of Disease 1 HC10: Repair mechanism
- Mechanisms of Disease 1 HC11: Pathology of inflammatory reactions
- Mechanisms of Disease 1 HC12: Introduction to infectious diseases
- Mechanisms of Disease 1 HC13: Bacteria
- Mechanisms of Disease 1 HC14: Viruses
- Mechanisms of Disease 1 HC15: Fungi and parasites
- Mechanisms of Disease 1 HC16: Invaders
- Mechanisms of Disease 1 HC17: Host versus invader
- Mechanisms of Disease 1 HC18: Immune deficiencies and infection risk
- Mechanisms of Disease 1 HC19: Pathology of infectious diseases
- Mechanisms of Disease 1 HC20: Diagnostics of infectious diseases
- Mechanisms of Disease 1 HC21: Essential microorganisms
- Mechanisms of Disease 1 HC extra: Mycobacterial infections (tuberculosis)
- Mechanisms of Disease 1 HC22: Antimicrobial therapy
- Mechanisms of Disease 1 HC23: Principles of antibiotic pharmacotherapy
- Mechanisms of Disease 1 HC24: Introduction MOOC
- Mechanisms of Disease 1 HC25: Epidemiology
- Mechanisms of Disease 1 HC26: Prevention and control
- Mechanisms of Disease 1 HC extra: COVID-19
- Mechanisms of Disease 1 HC27: Mechanisms of hypersensitivity reactions
- Mechanisms of disease 1 HC28: Pathology of allergy
- Mechanisms of Disease 1 HC29: Asthma
- Mechanisms of Disease 1 HC30: Pathology of autoimmunity
- Mechanisms of Disease 1 HC31: HLA and autoimmunity
- Mechanisms of Disease 1 HC32: Vasculitis
- Mechanisms of Disease 1 HC33: Systemic Lupus Erythematosus
- Mechanisms of Disease 1 HC35: Infections and autoimmunity
- Mechanisms of Disease 1 HC36: Immune cells in rheumatoid arthritis
- Mechanisms of Disease 1 HC37+38: Pharmacology: immunosuppression
- Mechanisms of Disease 1 HC39: Pathology of transplantation
Work for JoHo WorldSupporter?
Volunteering: WorldSupporter moderators and Summary Supporters
Volunteering: Share your summaries or study notes
Student jobs: Part-time work as study assistant in Leiden

Contributions: posts
Mechanisms of Disease 1 2020/2021 UL
Deze bundel bevat aantekeningen van alle hoorcolleges van het blok Mechanisms of Disease 1 van de studie Geneeskunde aan de Universiteit Leiden, collegejaar 2020/2021.
This bundle contains notes of all lectures from the module Mechanisms of Disease 1, Medicine, Leiden
...- Lees verder over Mechanisms of Disease 1 2020/2021 UL
- 2507 keer gelezen
- Login of registreer om te kunnen reageren
- 2240 keer gelezen
WorldSupporter insurances for backpackers, digital nomads, interns, students, volunteers or working abroad:
Search only via club, country, goal, study, topic or sector
Select any filter and click on Search to see results








